ORIGINAL ARTICLE

Neurological manifestation as an implication of COVID-19 pandemic at a hospital in Aceh, Indonesia

Syahrul Syahrul , Dessy Rahmawati Emril, Endang Mutiawati, Farida Farida, Imran Imran, Nasrul Musadir, Nova Dian Lestari, Nur Astini, Nurul Fajri, Ellya Nurfida, Rita Mulyana, Nona Suci Rahayu, Faza Nabila Syahrul

Syahrul Syahrul
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia. Email: syahrulsps@unsyiah.ac.id

Dessy Rahmawati Emril
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Endang Mutiawati
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Farida Farida
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Imran Imran
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Nasrul Musadir
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Nova Dian Lestari
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Nur Astini
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Nurul Fajri
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Ellya Nurfida
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Rita Mulyana
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Nona Suci Rahayu
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia

Faza Nabila Syahrul
Department of Neurology, School of Medicine, Universitas Syiah Kuala-Dr. Zainoel Abidin, Banda Aceh, Aceh, Indonesia
Online First: July 23, 2021 | Cite this Article
Syahrul, S., Emril, D., Mutiawati, E., Farida, F., Imran, I., Musadir, N., Lestari, N., Astini, N., Fajri, N., Nurfida, E., Mulyana, R., Rahayu, N., Syahrul, F. 2021. Neurological manifestation as an implication of COVID-19 pandemic at a hospital in Aceh, Indonesia. Bali Medical Journal 10(2): 623-627. DOI:10.15562/bmj.v10i2.2342


Introduction: Coronavirus disease 19 (COVID-19) has quickly spread to more than 200 countries as a global health pandemic. The outbreak of the COVID-19 infection in Wuhan (China) has brought its clinicians to investigate different manifestations, including neurological presentations of this novel infection. As of 12 October 2020, the number of deaths due to COVID-19 is 1.08 million worldwide, with 11,935 cases in Indonesia and 209 cases in Aceh. This study aimed to determine the neurological manifestations in patients confirmed with COVID-19.

Methods: A Retrospective cross-sectional study design from neurology patients who diagnosed with COVID-19 and were hospitalized at the Dr. Zainoel Abidin Hospital from March to September 2020. COVID-19 diagnosis was confirmed with polymerase chain reaction (PCR) swab test that met the inclusion and exclusion criteria.

Results: We collected 36 cases, consisting of 19 males (53%) and 17 females (47%) with a mean age of> 60 years 47%. According to the comorbidities data, 53% of patients were smoking, 47% had hypertension, 8% had diabetes mellitus, 8% had a history of stroke, and 8% had malignancy. Neurological manifestations included limbs weakness and cranial nerve paresis (55%), decreased consciousness (39%), and headache (22%). At admission, several patients had stroke (47%), cephalgia (14%), metabolic encephalopathy (8%), and vertigo (5%). Finally, 16 patients died during the period of observation.

Conclusion: Patients with COVID-19 commonly have neurological manifestations such as limb weakness, cranial nerve paresis, decreased consciousness, headache, dizziness, olfactory disturbances, and seizures.

References

Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13:667-73.

Keam S, Megawati D, Patel SK, Tiwari R, Dhama K, Harapan H. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infections. Rev Med Virol. 2020;30:e2123.

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.

World Health O. Coronavirus disease 2019 (COVID-19): situation report, 60. 2020.

Indonesia’s Task Force for Covid-19 and National Economic Recovery for Covid-19. Indonesia's Task Force for COVID-19. https://covid19goid/petasebaran (14 September 2020). 2021.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.

Syahrul S, Maliga HA, Ilmawan M, Fahriani M, Mamada SS, Fajar JK, et al. Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis. F1000Res. 2021;10:34.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683-90.

Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of Community Empowerment for Health. 3.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507-13.

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG; ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985.

Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM; open COVID-19 data working group, du Plessis L, Faria NR, Li R, Hanage WP, Brownstein JS, Layan M, Vespignani A, Tian H, Dye C, Cauchemez S, Pybus OG, Scarpino SV. The effect of human mobility and control measures on the COVID-19 epidemic in China. medRxiv. 2020;368(6490):493-497.

Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol. 2017; 198:4046-53.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.

Cancarevic I, Malik BH. SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease. Cureus. 2020;12:e8557.

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55.

Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142.

Kulkarni S, Jenner BL, Wilkinson I. COVID-19 and hypertension. J Renin Angiotensin Aldosterone Syst. 2020;21(2):1470320320927851. doi: 10.1177/1470320320927851.

Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. Journal of Clinical Virology. 2020;127:104354.

Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes Metab Syndr. 2020;14:1109-20.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5.

Liang WH, Guan WJ, Li CC, Li YM, Liang HR, Zhao Y, Liu XQ, Sang L, Chen RC, Tang CL, Wang T, Wang W, He QH, Chen ZS, Wong SS, Zanin M, Liu J, Xu X, Huang J, Li JF, Ou LM, Cheng B, Xiong S, Xie ZH, Ni ZY, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX. Clinical characteristics and outcomes of hospitalized patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020;55(6):2000562. doi: 10.1183/13993003.00562-2020.

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. Treasure Island (FL); 2021.

Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, et al. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front Neurol. 2020;11:518-25.

Khatoon F, Prasad K, Kumar V. Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol. 2020;26:619-30.

Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020;194:105921.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0